Griffin Asset Management, Inc. Viatris Inc Transaction History

Griffin Asset Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$9.2 - $12.26 $54,675 - $72,861	-5,943 Reduced 15.45%	32,517 $312,000
Q4 2022 Jan 20, 2023	SELL	$8.72 - $11.56 $87,191 - $115,588	-9,999 Reduced 20.63%	38,460 $0
Q3 2022 Oct 19, 2022	BUY	$8.48 - $11.13 $86,334 - $113,314	10,181 Added 26.6%	48,459 $413,000
Q2 2022 Jul 19, 2022	BUY	$9.95 - $12.27 $30,606 - $37,742	3,076 Added 8.74%	38,278 $401,000
Q1 2022 Apr 12, 2022	BUY	$9.81 - $15.4 $181,808 - $285,408	18,533 Added 111.18%	35,202 $383,000
Q4 2021 Jan 28, 2022	SELL	$12.09 - $14.68 $65,890 - $80,006	-5,450 Reduced 24.64%	16,669 $226,000
Q3 2021 Nov 05, 2021	BUY	$13.25 - $15.13 $136,660 - $156,050	10,314 Added 87.37%	22,119 $300,000
Q2 2021 Jul 28, 2021	BUY	$12.97 - $16.15 $153,110 - $190,650	11,805 New	11,805 $169,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Griffin Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Griffin Asset Management, Inc. with notifications on news.